Here, we review the current knowledge concerning tau proteins, tauopathies, and tau that is presumed to be a pathogenic factor in several neurodegenerative diseases, with the perspective that increasing insight will lead to new approaches in management and prevention. This evidence concerns the gene MAPT and neurodegenerative disease.